Latest updates
- In the press Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen
- In the press A day in the life of a Senior Scientist
- In the press Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)
- In the press Watch Exonate’s Dr. Catherine Beech OBE accept Top 21 #OnetoWatch award from Cofinitve
- In the press Exonate closes successful £1.5 million fundraising
- In the press Exonate’s CEO, Dr Catherine Beech OBE, to present at Pharmacology 2018
- In the press Listen to Exonate’s CEO Dr Catherine Beech speak at The Commonwealth Innovation Forum (TCIF) in Brisbane held on Thursday 5th April 2018.
- In the press Exonate’s CEO, Dr Catherine Beech, to present at BioTrinity 2018
- In the press Watch Exonate’s Chairman Sunil Shah and Angel Co Fund Investor Peter Cowley, feature in the British Business Bank Finance Guide video
- In the press Exonate’s CEO, Dr Catherine Beech to speak at The Commonwealth Innovation Forum (TCIF), Brisbane 2018
- In the press Watch Exonate’s principal scientist, Dr Jennifer Batson interviewed for Bermuda TV
- In the press Exonate’s principal scientist, Dr Jennifer Batson, to present at The Bermuda Principles Impact on Splicing 2nd Annual conference 2018 (BPIS)